188039-54-5

188039-54-5 structure

188039-54-5 structure

Name: palivizumab
Chemical Name: palivizumab
CAS Number: 188039-54-5
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways Anti-infection RSV
Create Date: 2018-07-10 16:13:36
Modify Date: 2024-01-11 15:51:59
Palivizumab (MEDI 493), a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection[1].

Name	palivizumab
Synonyms	PALIVIZUMAB

Description	Palivizumab (MEDI 493), a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection[1].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> RSV
References	[1]. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998 Sep;102(3 Pt 1):531-7.

No Any Chemical & Physical Properties